Cognition Therapeutics Inc (CGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -7,839 | N/A | N/A |
| Depreciation Amortization | 934 | N/A | N/A |
| Accounts receivable | 3,001 | N/A | N/A |
| Accounts payable and accrued liabilities | -364 | N/A | N/A |
| Other Working Capital | 3,067 | N/A | N/A |
| Other Operating Activity | -2,232 | 0 | 0 |
| Operating Cash Flow | $-3,433 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -10 | N/A | N/A |
| Investing Cash Flow | $-10 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 5,372 | N/A | N/A |
| Debt Repayment | -4 | N/A | N/A |
| Common Stock Issued | 47 | N/A | N/A |
| Other Financing Activity | 350 | 0 | 0 |
| Financing Cash Flow | $5,765 | $N/A | $N/A |
| Exchange Rate Effect | -23 | N/A | N/A |
| Beginning Cash Position | 2,890 | N/A | N/A |
| End Cash Position | 5,189 | N/A | N/A |
| Net Cash Flow | $2,299 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -3,433 | N/A | N/A |
| Capital Expenditure | -10 | N/A | N/A |
| Free Cash Flow | -3,443 | 0 | 0 |